These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38912229)

  • 21. Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials.
    Anglemyer A; Horvath HT; Bero L
    Cochrane Database Syst Rev; 2014 Apr; 2014(4):MR000034. PubMed ID: 24782322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Starting a conversation about estimands with public partners involved in clinical trials: a co-developed tool.
    Cro S; Kahan BC; Patel A; Henley A; C J; Hellyer P; Kumar M; Rahman Y; Goulão B
    Trials; 2023 Jul; 24(1):443. PubMed ID: 37408080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tell me what you want, what you really really want: Estimands in observational pharmacoepidemiologic comparative effectiveness and safety studies.
    Luijken K; van Eekelen R; Gardarsdottir H; Groenwold RHH; van Geloven N
    Pharmacoepidemiol Drug Saf; 2023 Aug; 32(8):863-872. PubMed ID: 36946319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assumption Trade-Offs When Choosing Identification Strategies for Pre-Post Treatment Effect Estimation: An Illustration of a Community-Based Intervention in Madagascar.
    Weber AM; van der Laan MJ; Petersen ML
    J Causal Inference; 2015 Mar; 3(1):109-130. PubMed ID: 26097800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Defining estimands using a mix of strategies to handle intercurrent events in clinical trials.
    Qu Y; Shurzinske L; Sethuraman S
    Pharm Stat; 2021 Mar; 20(2):314-323. PubMed ID: 33098267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Considering Questions Before Methods in Dementia Research With Competing Events and Causal Goals.
    Rojas-Saunero LP; Young JG; Didelez V; Ikram MA; Swanson SA
    Am J Epidemiol; 2023 Aug; 192(8):1415-1423. PubMed ID: 37139580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rethinking intercurrent events in defining estimands for tuberculosis trials.
    Pham TM; Tweed CD; Carpenter JR; Kahan BC; Nunn AJ; Crook AM; Esmail H; Goodall R; Phillips PP; White IR
    Clin Trials; 2022 Oct; 19(5):522-533. PubMed ID: 35850542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COVID-19 and the epistemology of epidemiological models at the dawn of AI.
    Ellison GTH
    Ann Hum Biol; 2020 Sep; 47(6):506-513. PubMed ID: 33228409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing the ratio of means as a causal estimand in clinical endpoint bioequivalence studies in the presence of intercurrent events.
    Lou Y; Jones MP; Sun W
    Stat Med; 2019 Nov; 38(27):5214-5235. PubMed ID: 31621943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estimand framework: Delineating what to be estimated with clinical questions of interest in clinical trials.
    Jin M; Liu G
    Contemp Clin Trials; 2020 Sep; 96():106093. PubMed ID: 32777382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estimating causal contrasts involving intermediate variables in the presence of selection bias.
    Valeri L; Coull BA
    Stat Med; 2016 Nov; 35(26):4779-4793. PubMed ID: 27411847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selection criteria and generalizability within the counterfactual framework: explaining the paradox of antidepressant-induced suicidality?
    Weisberg HI; Hayden VC; Pontes VP
    Clin Trials; 2009 Apr; 6(2):109-18. PubMed ID: 19342462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Causal interpretation of the hazard ratio in randomized clinical trials.
    Fay MP; Li F
    Clin Trials; 2024 Apr; ():17407745241243308. PubMed ID: 38679930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identifying Causal Estimands for Time-Varying Treatments Measured with Time-Varying (Age or Grade-Based) Instruments.
    Steiner PM; Park S; Kim Y
    Multivariate Behav Res; 2016; 51(6):865-8780. PubMed ID: 27540889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estimation of treatment effects in short-term depression studies. An evaluation based on the ICH E9(R1) estimands framework.
    Mitroiu M; Teerenstra S; Oude Rengerink K; Pétavy F; Roes KCB
    Pharm Stat; 2022 Sep; 21(5):1037-1057. PubMed ID: 35678545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survival-related Selection Bias in Studies of Racial Health Disparities: The Importance of the Target Population and Study Design.
    Howe CJ; Robinson WR
    Epidemiology; 2018 Jul; 29(4):521-524. PubMed ID: 29746369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overview of the epidemiology methods and applications: strengths and limitations of observational study designs.
    Colditz GA
    Crit Rev Food Sci Nutr; 2010; 50 Suppl 1(s1):10-2. PubMed ID: 21132580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantifying biases in causal models: classical confounding vs collider-stratification bias.
    Greenland S
    Epidemiology; 2003 May; 14(3):300-6. PubMed ID: 12859030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single-world intervention graphs for defining, identifying, and communicating estimands in clinical trials.
    Ocampo A; Bather JR
    Stat Med; 2023 Sep; 42(21):3892-3902. PubMed ID: 37340887
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Theory and performance of substitution models for estimating relative causal effects in nutritional epidemiology.
    Tomova GD; Gilthorpe MS; Tennant PW
    Am J Clin Nutr; 2022 Nov; 116(5):1379-1388. PubMed ID: 36223891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.